Skip to content

A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02015143
Acronym
CAFE-BD
Enrollment
970
Registered
2013-12-19
Start date
2012-01-31
Completion date
2014-12-31
Last updated
2013-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Unipolar Disorder

Brief summary

The purpose of this study was to investigate the reliability and validity of the bipolar index (BPX) to diagnosis bipolar disorder, and to verify the stability of it in identifying bipolar disorder; the secondary purpose was to understand the dynamic changes of bipolar disorder in natural status.

Interventions

None listed

Sponsors

Capital Medical University
CollaboratorOTHER
Shanghai Mental Health Center
CollaboratorOTHER
The First Hospital of Hebei Medical University
CollaboratorOTHER
Central South University
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Peking University
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 18-65 years old; 2. Be able to understand the content of assessment and cooperate; 3. Currently patients are depressive episode, and / or manic / hypomanic episode, also can be mood stable; 4. Currently according to diagnostic criteria of the U.S Diagnostic and Statistical Manual Fourth Edition of Mental Disease (DSM-IV) of bipolar disorder (Type I, II, rapid cycling, mixed episodes); 5. Currently according to diagnostic criteria of the U.S Diagnostic and Statistical Manual Fourth Edition of Mental Disease (DSM-IV) of depressive disorder; 6. No other mental illness or a history of physical disease,or patients with physical disease; 7. Not received modified ECT at least four weeks or more before entering the group.

Exclusion criteria

1. Can not understand the content of assessment and cooperate; 2. Meet the diagnosis criteria of schizophrenia and other psychotic disorders; 3. Meet the diagnosis criteria of Diagnosis of mental retardation or pervasive developmental disorder; 4. Clinically significant neurological disease or loss of consciousness more than one hour of traumatic brain injury;

Design outcomes

Primary

MeasureTime frame
Test-retest reliability of the scaleone year later

Secondary

MeasureTime frame
Cronbach's α coefficient of the scaleone year later

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026